Diclofenac and misoprostol vs Deferasirox

Interacting Drugs
Diclofenac and misoprostol
vs
Deferasirox
Security Level
Minor, Monitor Therapy
Mechanism
Deferasirox: Nonsteroidal Anti-Inflammatory Agents may enhance the adverse/toxic effect of Deferasirox. Specifically, the risk for GI ulceration/irritation or GI bleeding may be increased.
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Diclofenac and misoprostol vs Deferasirox